Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
4.700
-0.090 (-1.88%)
At close: Feb 20, 2026, 4:00 PM EST
4.770
+0.069 (1.48%)
After-hours: Feb 20, 2026, 5:22 PM EST
Taysha Gene Therapies Market Cap
Taysha Gene Therapies has a market cap or net worth of $1.29 billion as of February 20, 2026. Its market cap has increased by 271.71% in one year.
Market Cap
1.29B
Enterprise Value
1.06B
1-Year Change
271.71%
Ranking
Category
Stock Price
$4.70
Market Cap Chart
Since the IPO on September 24, 2020, Taysha Gene Therapies's market cap has increased from $690.43M to $1.29B, an increase of 86.47%. That is a compound annual growth rate of 12.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 1.29B | -14.55% |
| Dec 31, 2025 | 1.51B | 324.92% |
| Dec 31, 2024 | 354.55M | 7.14% |
| Dec 29, 2023 | 330.92M | 134.50% |
| Dec 30, 2022 | 141.12M | -68.52% |
| Dec 31, 2021 | 448.22M | -55.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Savara | 1.37B |
| Trevi Therapeutics | 1.36B |
| Immatics | 1.35B |
| MoonLake Immunotherapeutics | 1.34B |
| EyePoint | 1.27B |
| DBV Technologies | 1.27B |
| Inventiva | 1.26B |
| Nanobiotix | 1.24B |